Cargando…
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease
Cognitive deficits occur in over half of multiple sclerosis patients, with hippocampal-dependent learning and memory commonly impaired. Data from in vivo MRI and post-mortem studies in MS indicate that the hippocampus is targeted. However the relationship between structural pathology and dysfunction...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343001/ https://www.ncbi.nlm.nih.gov/pubmed/22525427 http://dx.doi.org/10.1038/labinvest.2012.76 |
_version_ | 1782359343716368384 |
---|---|
author | Ziehn, Marina O. Avedisian, Andrea A. Dervin, Shannon M. O’Dell, Thomas J. Voskuhl, Rhonda R. |
author_facet | Ziehn, Marina O. Avedisian, Andrea A. Dervin, Shannon M. O’Dell, Thomas J. Voskuhl, Rhonda R. |
author_sort | Ziehn, Marina O. |
collection | PubMed |
description | Cognitive deficits occur in over half of multiple sclerosis patients, with hippocampal-dependent learning and memory commonly impaired. Data from in vivo MRI and post-mortem studies in MS indicate that the hippocampus is targeted. However the relationship between structural pathology and dysfunction of the hippocampus in MS remains unclear. Hippocampal neuropathology also occurs in experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS. While estrogen treatment of EAE has been shown to be anti-inflammatory and neuroprotective in the spinal cord, it is unknown if estrogen treatment may prevent hippocampal pathology and dysfunction. In the current study we examined excitatory synaptic transmission during EAE and focused on pathological changes in synaptic protein complexes known to orchestrate functional synaptic transmission in the hippocampus. We then determined if estriol, a candidate hormone treatment, was capable of preventing functional changes in synaptic transmission and corresponding hippocampal synaptic pathology. Electrophysiological studies revealed altered excitatory synaptic transmission and paired-pulse facilitation during EAE. Neuropathological experiments demonstrated that there were decreased levels of pre-and postsynaptic proteins in the hippocampus, diffuse loss of myelin staining and atrophy of the pyramidal layers of hippocampal cornu ammonis 1 (CA1). Estriol treatment prevented decreases in excitatory synaptic transmission and lessened the effect of EAE on paired-pulse facilitation. In addition, estriol treatment prevented several neuropathological alterations that occurred in the hippocampus during EAE. Cross-modality correlations revealed that deficits in excitatory synaptic transmission were significantly correlated with reductions in trans-synaptic protein binding partners known to modulate excitatory synaptic transmission. To our knowledge, this is the first report describing a functional correlate to hippocampal neuropathology in any MS model. Furthermore, a treatment was identified which prevented both deficits in synaptic function and hippocampal neuropathology. |
format | Online Article Text |
id | pubmed-4343001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
record_format | MEDLINE/PubMed |
spelling | pubmed-43430012015-02-27 Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease Ziehn, Marina O. Avedisian, Andrea A. Dervin, Shannon M. O’Dell, Thomas J. Voskuhl, Rhonda R. Lab Invest Article Cognitive deficits occur in over half of multiple sclerosis patients, with hippocampal-dependent learning and memory commonly impaired. Data from in vivo MRI and post-mortem studies in MS indicate that the hippocampus is targeted. However the relationship between structural pathology and dysfunction of the hippocampus in MS remains unclear. Hippocampal neuropathology also occurs in experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS. While estrogen treatment of EAE has been shown to be anti-inflammatory and neuroprotective in the spinal cord, it is unknown if estrogen treatment may prevent hippocampal pathology and dysfunction. In the current study we examined excitatory synaptic transmission during EAE and focused on pathological changes in synaptic protein complexes known to orchestrate functional synaptic transmission in the hippocampus. We then determined if estriol, a candidate hormone treatment, was capable of preventing functional changes in synaptic transmission and corresponding hippocampal synaptic pathology. Electrophysiological studies revealed altered excitatory synaptic transmission and paired-pulse facilitation during EAE. Neuropathological experiments demonstrated that there were decreased levels of pre-and postsynaptic proteins in the hippocampus, diffuse loss of myelin staining and atrophy of the pyramidal layers of hippocampal cornu ammonis 1 (CA1). Estriol treatment prevented decreases in excitatory synaptic transmission and lessened the effect of EAE on paired-pulse facilitation. In addition, estriol treatment prevented several neuropathological alterations that occurred in the hippocampus during EAE. Cross-modality correlations revealed that deficits in excitatory synaptic transmission were significantly correlated with reductions in trans-synaptic protein binding partners known to modulate excitatory synaptic transmission. To our knowledge, this is the first report describing a functional correlate to hippocampal neuropathology in any MS model. Furthermore, a treatment was identified which prevented both deficits in synaptic function and hippocampal neuropathology. 2012-04-23 2012-08 /pmc/articles/PMC4343001/ /pubmed/22525427 http://dx.doi.org/10.1038/labinvest.2012.76 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Ziehn, Marina O. Avedisian, Andrea A. Dervin, Shannon M. O’Dell, Thomas J. Voskuhl, Rhonda R. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title | Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title_full | Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title_fullStr | Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title_full_unstemmed | Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title_short | Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
title_sort | estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343001/ https://www.ncbi.nlm.nih.gov/pubmed/22525427 http://dx.doi.org/10.1038/labinvest.2012.76 |
work_keys_str_mv | AT ziehnmarinao estriolpreservessynaptictransmissioninthehippocampusduringautoimmunedemyelinatingdisease AT avedisianandreaa estriolpreservessynaptictransmissioninthehippocampusduringautoimmunedemyelinatingdisease AT dervinshannonm estriolpreservessynaptictransmissioninthehippocampusduringautoimmunedemyelinatingdisease AT odellthomasj estriolpreservessynaptictransmissioninthehippocampusduringautoimmunedemyelinatingdisease AT voskuhlrhondar estriolpreservessynaptictransmissioninthehippocampusduringautoimmunedemyelinatingdisease |